We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App

Siemens Healthineers Showcases Advanced Diagnostics Analyzers

By LabMedica International staff writers
Posted on 07 Feb 2018
Print article
Image: The Atellica range was highlighted at MEDLAB 2018 (Photo courtesy of Siemens Healthineers).
Image: The Atellica range was highlighted at MEDLAB 2018 (Photo courtesy of Siemens Healthineers).
Siemens Healthineers (Erlangen, Germany) showcased its Atellica range of advanced diagnostics analyzers at MEDLAB Middle East, the world’s largest attended laboratory and IVD exhibition and conference, held from February 5-8, 2018 in Dubai, UAE.
Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market. Among the exhibitors at the event was Siemens Healthineers, which displayed its Atellica range of flexible and scalable automation-ready immunoassay and chemistry analyzers, fully-automated high-volume coagulation system, and automated urinalysis system.
At MEDLAB Middle East 2018, Siemens exhibited its Atellica Solution, which is designed to address common clinical laboratory challenges and integrates immunoassay and clinical chemistry analyzers with the new standard in sample-management technology so laboratories can focus on driving better outcomes. Also on display was the company’s Atellica COAG 360 System, a fully automated high volume coagulation analyzer that simplifies lab operations by unifying five methodologies on one platform, streamlines hemostasis workflow through intelligent reagent and consumable management, and delivers infinite possibilities by being the first to integrate LOCI technology in specialty hemostasis testing.
Siemens also showcased the Atellica 1500 Automated Urinalysis System, which combines the CLINITEK Novus Analyzer and the new Atellica UAS 800 Analyzer. The truly digital automated urinalysis system sets new standards for accuracy and efficiency and allows laboratories to manage more samples with less staff in shorter time without compromising on high-quality results. The company also showcased the Atellica MDX 160 Molecular System, which provides innovation in the molecular laboratory by improving workflow and consolidation while providing for flexibility and customization.
Other instruments showcased by Siemens at this year’s MEDLAB Middle East included the Atellica NEPH 630 System, a mid-volume dedicated nephelometric analyzer that simplifies lab operations in specialty protein testing, and the handheld epoc Blood Analysis System which goes wherever patients are located and provides lab-quality results on the spot. Siemens also demonstrated the Atellica PM 1.0 Software, which is the only lab management system that allows the management of laboratory’s processes, including alerts, remote management of instruments, and monitoring of onboard inventory and testing progress—all from one screen.
Gold Supplier
D-Dimer Rapid Test
Clostridium Difficile Test
Simplexa C. difficile Direct Kit
TSH (Thyroid Stimulating Hormone) Test
Kemilo TSH Kit
Lab Incubator

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.